- Finalist, Trinity Challenge 2025 — programme and category to be confirmed before publication.
- Peer-reviewed research published in the American Journal of Infection Control and the Indian Journal of Medical Microbiology.
- WHO India collaboration reflects research participation in a specific study, not a platform-wide endorsement.
Clinical research, published.
Ibhar supports clinical research and collaborative studies that generate real-world insights into infection prevention practices, antimicrobial resistance patterns, and stewardship outcomes. Through partnerships with hospitals, clinicians and research institutions, these initiatives translate operational healthcare data into evidence that informs clinical decision-making, strengthens stewardship programs, and advances knowledge in infection prevention and antimicrobial resistance.
Hand Hygiene Study
This multicentric observational study evaluated hand hygiene compliance among healthcare workers across 92 hospitals in India using a digital audit tool based on the WHO Five Moments framework. More than 160,000 hand hygiene opportunities were analyzed to measure adherence across ICUs and wards. The findings highlight variations in compliance and underscore the importance of digital surveillance systems in strengthening infection prevention programs and reducing healthcare-associated infections.
View More →American Journal of Infection Control
Hand hygiene is a significant component involved in preventing transmission of health care associated infections including COVID-19. Compliance to hand hygiene among the health care workers (HCWs) requires evaluation and timely feedback. “You can’t improve what you can’t measure” is a famous saying and this multicentric study was designed to measure hand hygiene compliance and have a bird’s eye view on hand hygiene compliance in COVID Intensive Care Units (ICUs) and wards across India.
View More →The Effectiveness of a Hospital-Based Antimicrobial Stewardship Program
This three-year observational study evaluated the impact of a hospital-based antimicrobial stewardship program on antibiotic utilization, prescribing compliance, and resistance trends. The results demonstrate how multidisciplinary stewardship interventions can improve prescribing practices and support better infection control and patient outcomes in hospital settings.
View More →Built for programmes, not just single workflows.
Connecting surveillance, microbiology, clinical practice and governance creates value beyond any one ward or department — supporting institutional AMR programmes and national strategies alike. Deployment, data flows and integration scope are assessed individually for every setting; nothing here assumes universal interoperability or automatic cross-hospital aggregation.
Questions IPC teams and committees ask first.
An infection prevention & control and antimicrobial stewardship platform from Ibhar Technologies, connecting surveillance, microbiology and prescribing on one governed data model.
Yes. It follows CDC and WHO guidance, with CLSI-aligned microbiology workflows and antibiograms.
A rules engine evaluates vitals, symptoms and cultures to flag events, MDROs and outbreak patterns, with automatic escalation to the relevant team.
Prescriptions originate in the HIS. The platform layers in antibiograms, dosing suggestions, approvals, adherence monitoring, time-outs and DDD/DOT tracking.
CAUTI, CLABSI, VAE and SSI, with automated compliance trends and committee-ready reports.
Yes. It runs alongside these systems and other HIS/LIS platforms, adding an infection prevention and stewardship layer. Data connections depend on available interfaces and are validated during implementation.
Typically three to six months, scoped to the hospital's own high-risk areas and run with the hospital's existing teams before any wider rollout.